Published Abstracts
  1. Nalesnik MA, Jaffe R, Rabin B, Yunis E, Fennell R, Atchison RW, Ho M: Lymphoproliferative syndrome in Cyclosporine-A treated allograft recipients. Lab Invest 50:42A-43A, 1984.
  2. Shinozuka H, Demetris AJ, Witkowski LA, Perera MIR, Nalesnik MA, Gill TJ: Experimental models of Cyclosporine (CyA) induced lymphoproliferative disorders. Fed Proc 43:662, 1984.
  3. Locker J and Nalesnik M: Epstein-Barr Virus (EBV), Immunogloublin, and Myc genes in the Post-Transplant Lymphoproliferative Disorder (PTLD). FASEB J 2:5):A1158, 1988.
  4. Nalesnik MA and Locker J: EBV-associated lymphoproliferative disorders in a large transplant population. J Exp Clin Cancer Res 7(3):81, 1988.
  5. Ho M, Breining MK, Nalesnik MA, Locker J, Dummer JS, Miller G, Starzl TE: EBV-associated post-transplant lymphoproliferative disease (PTLD) in Pittsburgh. J Exp Clin Cancer Res 7(3):91, 1988.
  6. Brancazio L, Banner B, Hakala T, Nalesnik M: Post-Transplant Lymphoproliferative Disorders in Renal Allografts. Lab Invest, 1988.
  7. Gollin SM, Cen H, Storto PD, Wyman PL, Malone P, Anderson SJ, Herberman RB, Nalesnik MA, Locker J, Ho M, McKnight J: Consistent non-clonal abnormalities in post-transplant lymphoproliferative disease. Am J Hum Gener 47(3): A7, 1990.
  8. Zeevi A, Spichty K, Lockwood C, Pavlick M, Keenan R, Griffith B, Armitage J, Nalesnik M, Demetris J, Reyes J, Tzakis A, Reinsmoen N, Starzl TE: Different T helper subset activation during cytomegalovirus (CMV) and Epstein Barr virus (EBV) infection in solid organ transplantation. 19th Annual Meeting - American Society for Histocompatibility and Immunogenetics, October 207, 1993, Phoenix, AZ.
  9. Zeevi A, Pavlick M, Ricordi C, Demetris J, Tzxakis A, Rybka WB, Nalesnik M, Fontes PAC, Ukah FO, Ball E, Marino I, Fung J, Starzl TE: Host anti-donor cellular responses associated with resolution of graft versus host disease in a combined liver-bone marrow transplant recipient. 19th Annual Meeting American Society for Histocompatibility and Immunogenetics, October 2-7, 1994, Phoenix, AZ.
  10. Tzakis AG, Fontes PA, Ramos H, Mazariegos G, Nalesnik M, Demetris AJ, Rybka W, Ricordi C, Trucco M, Zeevi A, Selby R, Fung JJ, Starzl TE: Chimerism diagnosis and outocme in graft verus host disease after orthotopic liver transplantation. Hepatology, September 1993, P. 744.
  11. Wu TT, Swerdkow SH, Locker J, Dickman PS, Jaffe R, Nalesnik MA: Recurrent EBV-associated tumors after solid organ transplants. Lab Invest 70:128A, 1994.
  12. Randhawa PS, Zeevi A, Alvares C, Gollin S, Agostini R, Yunis E, Saidman S, Contis L, Demetris AJ and Nalesnik MA: Morphologic and immunophenotypic characterization of a cell line derived from liver tissue with epstein-barr virus associated post-transplant lymphoproliferative disease. In Vitro Cell Dev Biol 30A:400-406, 1994.
  13. Cicalese L, Caraceni P, Nalesnik MA, Van Thiel DH, Lee KKW, Schraut WH: Oxygen free radical (OFR) production and neutrophil infiltration are related to mucosal injury during reperfusion after rat small bowel transplantation, Accepted, Association for Academic Surgery, November 16-19, 1994.
  14. Fiel I, Antonio L, Nalesnik MA, Thung SN, Gerber MA: The cell origin of ductular hepatocytes. Experimental Biology, Accepted for platform and poster, April 4-9, 1995.
  15. Colson YL, Zadach K, Nalesnik M, Ildstad ST: Mixed allogeneic chimerist (A+B->A) prevents chronic rejection for primarily vascularized cardiac allografts. Submitted, ASTS Meeting, Chicago, 1995.
  16. Finn OJ, McKolanis JR, Nalesnik MA, Clarke MR, Lotze MT, Ochoa AC: T cell defects in advanced breast, pancreatic and colon cancer and improvements after vaccination with mucin peptide. Submitted, AACR, December, 1995.
  17. Mattsson P, Zeevi A, Cai J, Yousem S, Hoffman R, Nalesnik M, Burckart G, Griffith BP: The effect of Aminoguanidine and Cyclosporine on lung allograft rejection. Submitted, ISHLT Meeting, September, 1995.
  18. Green M, Wilson J, Nalesnik M, Breinig M, Shpilberg O, Reyes J: Incidence of post-transplant lymphoproliferative disease (PTLD) among organ transplant recipients under Tacrolimus immunosuppression. Submitted, ICAAC Meeting, San Francisco, 1995.
  19. Jain AB, Yee L, Nalesnik M, Fung JJ, Reyes J, Rakela J, Starzl TE: DeNovo non-lymphoid malignancies, following liver transplantation under Tacrolimus. Submitted, American Gastroenterological Association & American Association for the Study of Liver Diseases, May, 1996.
  20. Nalesnik M, Pham S, Rao A, Zeevi A, Elder E, Whiteside T, Rybka W, Keenan R, Griffith B, Rowe D, Fung J, Starzl TE: Cellular therapy of posttransplant lymphoproliferative disorders (PTLD) arising in solid organ allograft recipients. Submitted, ASTP, January, 1996.
  21. Mattsson P, Zeevi A, Cai J, Yousem S, Hoffman R, Nalesnik M, Burckart G, Griffith B: The effect of Aminoguanidine and Cyclosporine on lung allograft rejection. Accepted, The Society of Thoracic Surgeons, January, 1996.
  22. Randhawa P, Demetris A, Nalesnik M: Histopathology of renal post-transplant lymphoproliferative disease and severe acute rejection: A comparative study using the Banff schema. Submitted, Transplantation Society, January, 1996.
  23. Reyes J, Green M, Bueno J, Furukawa H, Nalesnik M, Yunis E, Kocoshis S, Mieles L, Todo S, Starzl TE: Spectrum of Epstein Barr virus disease after intestinal transplantation in humans. Submitted, Transplantation Society, January, 1996.
  24. Madariaga JR, Subbotin VM, Lopez SR, Shahin M, Ferres J, Dvorchik I, Subotin MV, Wang Z, Wakizaka Y, Nalesnik MA, Carr BI, Fung JJ, Valdivia LA, Rao AS, Starzl TE: New quantitative experimental model of syngeneic hepatoma development in buffalo rat. Submitted, Cell Transplant Society, April, 1996.